Drug Shortage Report for MYLAN-OMEPRAZOLE
Report ID | 19496 |
Drug Identification Number | 02329433 |
Brand name | MYLAN-OMEPRAZOLE |
Common or Proper name | OMEPRAZOLE |
Company Name | MYLAN PHARMACEUTICALS ULC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | OMEPRAZOLE |
Strength(s) | 20MG |
Dosage form(s) | CAPSULE (DELAYED RELEASE) |
Route of administration | ORAL |
Packaging size | 100BT, 500BT |
ATC code | A02BC |
ATC description | DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2017-09-08 |
Actual start date | 2017-09-11 |
Estimated end date | Unknown |
Actual end date | 2018-12-20 |
Shortage status | Resolved |
Updated date | 2020-04-22 |
Company comments | Discontinued in ID 48569 |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v30 | 2020-04-22 | English | Compare |
v29 | 2018-05-04 | French | Compare |
v28 | 2018-05-04 | English | Compare |
v27 | 2018-04-13 | French | Compare |
v26 | 2018-04-13 | English | Compare |
v25 | 2018-03-19 | French | Compare |
v24 | 2018-03-19 | English | Compare |
v23 | 2018-01-17 | French | Compare |
v22 | 2018-01-17 | English | Compare |
v21 | 2017-10-13 | French | Compare |
v20 | 2017-10-13 | English | Compare |
v19 | 2017-10-05 | French | Compare |
v18 | 2017-10-05 | English | Compare |
v17 | 2017-09-13 | French | Compare |
v16 | 2017-09-13 | English | Compare |
v15 | 2017-09-09 | English | Compare |
v14 | 2017-09-08 | French | Compare |
v13 | 2017-09-08 | English | Compare |
v12 | 2017-09-08 | English | Compare |
v11 | 2017-09-05 | English | Compare |